|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-1-29
|
|
pubmed:abstractText |
Infections with methicillin-resistant Staphylococcus species (MRSS) are associated with higher treatment costs than infections with methicillin-sensitive Staphylococcus species in the United States--partly because of an increased length of hospital stay (LOS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3173-89
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14749155-Acetamides,
pubmed-meshheading:14749155-Administration, Oral,
pubmed-meshheading:14749155-Anti-Bacterial Agents,
pubmed-meshheading:14749155-Anti-Infective Agents,
pubmed-meshheading:14749155-Costs and Cost Analysis,
pubmed-meshheading:14749155-Female,
pubmed-meshheading:14749155-Hospitals, Veterans,
pubmed-meshheading:14749155-Humans,
pubmed-meshheading:14749155-Injections, Intravenous,
pubmed-meshheading:14749155-Los Angeles,
pubmed-meshheading:14749155-Male,
pubmed-meshheading:14749155-Methicillin Resistance,
pubmed-meshheading:14749155-Oxazolidinones,
pubmed-meshheading:14749155-Staphylococcal Infections,
pubmed-meshheading:14749155-Vancomycin
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species.
|
|
pubmed:affiliation |
Department of Clinical Pharmacy, University of Colorado Health Sciences Center School of Pharmacy, Denver, Colorado 80262, USA. marianne.mccollum@uchsc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
